Phase I-Ib/II Study of MBG453 as Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies
Clinical trial NCT02608268 · TERMINATED
Trial details
- NCT number
- NCT02608268
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-23
- Primary completion
- 2022-08-30
- Enrollment
- 252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.